, Tracking Stock Market Picks
Enter Symbol:
Mannkind Corporation (MNKD) [hlAlert]

Neutral MNKD

Mannkind Corporation (MNKD) downgraded to Neutral by BofA/Merrill

Posted on: Friday,  Jun 7, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Neutral Mannkind Corporation (NASDAQ: MNKD) on 06/07/2013. Previously BofA/Merrill rated Buy Mannkind Corporation
(NASDAQ: MNKD) on 11/05/2012., when the stock price was $2.02. Since then, Mannkind Corporation has gained 268.32% of its value until BofA/Merrill rated MNKD Underperform on 06/07/2013, when the price was $7.44. .

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/6/2013 8:25 AM Sell
as of 12/13/2013
1 Week up  2.73 %
1 Month up  4.04 %
3 Months up  15.44 %
1 YTD up  238.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/7/2013 8:25 AM Hold
11/5/2012 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy